Anti-LRCH2 monoclonal antibody

Pre-made anti-LRCH2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to LRCH2/LRCH2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2580-Ab-1/ GM-Tg-hg-IP2580-Ab-2Anti-Human LRCH2 monoclonal antibodyHuman
GM-Tg-rg-IP2580-Ab-1/ GM-Tg-rg-IP2580-Ab-2Anti-Rat LRCH2 monoclonal antibodyRat
GM-Tg-mg-IP2580-Ab-1/ GM-Tg-mg-IP2580-Ab-2Anti-Mouse LRCH2 monoclonal antibodyMouse
GM-Tg-cynog-IP2580-Ab-1/ GM-Tg-cynog-IP2580-Ab-2Anti-Cynomolgus/ Rhesus macaque LRCH2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2580-Ab-1/ GM-Tg-felg-IP2580-Ab-2Anti-Feline LRCH2 monoclonal antibodyFeline
GM-Tg-cang-IP2580-Ab-1/ GM-Tg-cang-IP2580-Ab-2Anti-Canine LRCH2 monoclonal antibodyCanine
GM-Tg-bovg-IP2580-Ab-1/ GM-Tg-bovg-IP2580-Ab-2Anti-Bovine LRCH2 monoclonal antibodyBovine
GM-Tg-equg-IP2580-Ab-1/ GM-Tg-equg-IP2580-Ab-2Anti-Equine LRCH2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2580-Ab-1/ GM-Tg-hg-IP2580-Ab-2; GM-Tg-rg-IP2580-Ab-1/ GM-Tg-rg-IP2580-Ab-2;
GM-Tg-mg-IP2580-Ab-1/ GM-Tg-mg-IP2580-Ab-2; GM-Tg-cynog-IP2580-Ab-1/ GM-Tg-cynog-IP2580-Ab-2;
GM-Tg-felg-IP2580-Ab-1/ GM-Tg-felg-IP2580-Ab-2; GM-Tg-cang-IP2580-Ab-1/ GM-Tg-cang-IP2580-Ab-2;
GM-Tg-bovg-IP2580-Ab-1/ GM-Tg-bovg-IP2580-Ab-2; GM-Tg-equg-IP2580-Ab-1/ GM-Tg-equg-IP2580-Ab-2
Products NameAnti-LRCH2 monoclonal antibody
Formatmab
Target NameLRCH2
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-LRCH2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2580-Ag-1Recombinant multi-species LRCH2/ dA204F4.4 protein


    Target information

    Target IDGM-IP2580
    Target NameLRCH2
    Gene ID57631,210297,680591,708436,492078,101100373,100336559,100053980
    Gene Symbol and SynonymsdA204F4.4,LRCH2,mKIAA1495
    Uniprot AccessionQ5VUJ6
    Uniprot Entry NameLRCH2_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000130224
    Target ClassificationN/A

    The target: LRCH2, gene name: LRCH2, also named as dA204F4.4. This gene encodes a member of the leucine-rich repeat and calponin homology domain-containing protein family. These family members contain multiple N-terminal leucine-rich repeats, in addition to a C-terminal calponin homology domain, a type of domain that mediates interactions with actin filaments. These proteins are conserved across animal species, and studies of a similar Drosophila protein indicate a function as a cytoskeletal scaffolding protein. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Sep 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.